VALIC Company I Health Sciences Fund (VCHSX)

19.97
Net Asset Value
-1.24%
1 Day
-8.31%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.09%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital growth. The fund normally invests at least 80% of its net assets in the common stocks of companies engaged in the research- development- production- or distribution of products or services related to health care- medicine- or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size- the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks- which include non-dollar denominated securities traded outside the U.S.

Performance

1 month-1.09% 3 years+4.76%
3 months-2.89% 5 years+17.57%
1 year+19.67% Since inception+10.97%
Data through --

Peer Comparisonvs. Health

 VCHSXCategory
Performance 5-yr return+17.57%+13.64%
Expense ratio1.09%1.20%
Risk 5 year sharpe ratio1.100.89
Net assets$746.6M$219.9M
Average market cap$24.5B$10.0B
Average P/E25.322.2
Portfolio turnover30%30%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVALIC
Fund manager & tenureZiad Bakri / 2 Years
Minimal initial investment$0.00
Minimum IRA investment--

Holdings

U.S. stock92.68%
International stock5.89%
Other0.97%
Cash0.38%
Fixed income0.08%
Top 5 Sectors
Portfolio weighting
Healthcare 93.57%
Consumer service 1.09%
Industrial materials 0.89%
Financial service 0.35%
Hardware 0.19%
Top 10 Holdings
Portfolio weighting
UNH UnitedHealth6.87%
BDX Becton Dickinson and Co4.49%
ISRG Intuitive Surgical4.39%
VRTX Vertex Pharmaceuticals Inc3.41%
CI Cigna Corp2.73%
ANTM WellPoint2.54%
SAGE SAGE Therapeutics Inc2.45%
ABBV AbbVie2.44%
SYK Stryker Corp2.34%
A Agilent Technologies Inc2.20%